Projects per year
Personal profile
Biography
The aim of our research is to determine imaging, genomic, other biomarkers in the early diagnosis of neurogenerative diseases (e.g. Alzheimers Disease), apply artificial intelligence for diagnoses and test new therapeutic agents in clinical trials.
Our research centres on pre-clinical and translational clinical imaging in neurological disease but also some non-neurological diseases. We utilize state of the art and ultra-high field MRI, PET, CT, magnetic particle imaging, photon microscopy approaches towards imaging pathology. We also house a data warehouse and repository for imaging, genomics, biomarker, pathology and other data to be used for machine learning, deep learning, artificial intelligence applications in diagnostics and therapeutics. We also perform pre-clinical and clinical trials on novel therapeutics in neurodegenerative diseases and non-neurological diseases.
External positions
Head of Diagnostic and Interventional Radiology research, Alfred Health
Research area keywords
- Neuroscience
- Alzheimer's Disease
- Artificial intelligence
- Imaging
- Radiology, Radiography, Ultrasound, Imaging, Evidence Based Practice
- Traumatic brain injury
- MRI
- Neuroimaging
- Informatics
- Bioinformatics
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2018 2021
- 1 Active
Next Generation of bespoke treatments: Artificial intelligence aiding in prognoses in treatment plans
Law, M. & Seah, J.
18/12/18 → 31/12/21
Project: Research
Research Output 1997 2019
1
Citation
(Scopus)
7-Tesla MRI of the brain in a research subject with bilateral, total knee replacement implants: Case report and proposed safety guidelines
Barisano, G., Culo, B., Shellock, F. G., Sepehrband, F., Martin, K., Stevens, M., Wang, D. J., Toga, A. W. & Law, M., 1 Apr 2019, In : Magnetic Resonance Imaging. 57, p. 313-316 4 p.Research output: Contribution to journal › Article › Other › peer-review
1
Citation
(Scopus)
Assessment of metallic patient support devices and other items at 7-Tesla: Findings applied to 46 additional devices
Culo, B., Valencerina, S., Law, M. & Shellock, F. G., 1 Apr 2019, In : Magnetic Resonance Imaging. 57, p. 250-253 4 p.Research output: Contribution to journal › Article › Research › peer-review
Blood-based inflammatory biomarkers for predicting therapeutic response in regional brain volume changes in patients with alzheimer’s disease
Mishra, A., Hernandez, G. D., Lopez, C., Aydogan, D., Shi, Y., Law, M., Schneider, L. S. & Brinton, R. D., Jul 2019, In : Alzheimer's and Dementia. 15, 7 Supp, 1 p.Research output: Contribution to journal › Meeting Abstract › Other › peer-review
55
Citations
(Scopus)
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., Benzinger, T. L. S., Fagan, A. M., Ringman, J. M., Schneider, L. S., Morris, J. C., Chui, H. C., Law, M., Toga, A. W. & Zlokovic, B. V., 1 Feb 2019, In : Nature Medicine. 25, 2, p. 270-276-+ 20 p.Research output: Contribution to journal › Article › Research › peer-review
Brain imaging of vascular dysfunction as an early biomarker of cognitive decline
Montagne, A., Sweeney, M. D., Sagare, A. P., Nation, D. A., Harrington, M. G., Chui, H. C., Law, M., Toga, A. W. & Zlokovic, B. V., Jul 2019, In : Alzheimer's and Dementia. 15, 7 Supp, 1 p.Research output: Contribution to journal › Meeting Abstract › Other › peer-review